BR9917500A - Terapia gênica baseada em célula para o sistema pulmonar - Google Patents

Terapia gênica baseada em célula para o sistema pulmonar

Info

Publication number
BR9917500A
BR9917500A BR9917500-2A BR9917500A BR9917500A BR 9917500 A BR9917500 A BR 9917500A BR 9917500 A BR9917500 A BR 9917500A BR 9917500 A BR9917500 A BR 9917500A
Authority
BR
Brazil
Prior art keywords
cell
based gene
gene therapy
patient
pulmonary system
Prior art date
Application number
BR9917500-2A
Other languages
English (en)
Inventor
Duncan J Stewart
Original Assignee
An Go Gen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by An Go Gen Inc filed Critical An Go Gen Inc
Publication of BR9917500A publication Critical patent/BR9917500A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
    • C12Y114/13039—Nitric-oxide synthase (NADPH dependent) (1.14.13.39)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Resumo da Patente de Invenção para "TERAPIA GêNICA BASEADA EM CéLULA PARA O SISTEMA PULMONAR". A transferência de gene baseada em célula é realizada através de administração de fibroblastos de origem dérmica transfectados ou outra contendo um transgene expressível que codifica um fator angiogênico ou outro fator terapêutico à circulação pulmonar de um paciente onde as células expressam e secretam produtos de expressão do transgene para atuar localmente no local de expressão e, em alguns casos, serem transportadas pela circulação do paciente para outros órgãos do corpo. O processo é especialmente útil no tratamento de hipertensão pulmonar por meio dos fatores angiogênicos expressos.
BR9917500-2A 1999-09-23 1999-09-23 Terapia gênica baseada em célula para o sistema pulmonar BR9917500A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA1999/000869 WO2001021184A1 (en) 1999-09-23 1999-09-23 Cell-based gene therapy for the pulmonary system

Publications (1)

Publication Number Publication Date
BR9917500A true BR9917500A (pt) 2002-05-21

Family

ID=4173386

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9917500-2A BR9917500A (pt) 1999-09-23 1999-09-23 Terapia gênica baseada em célula para o sistema pulmonar

Country Status (11)

Country Link
EP (2) EP1839667B1 (pt)
JP (1) JP2003509463A (pt)
AT (1) ATE364387T1 (pt)
AU (1) AU5724499A (pt)
BR (1) BR9917500A (pt)
CA (1) CA2383093A1 (pt)
DE (1) DE69936320T2 (pt)
ES (1) ES2546937T3 (pt)
IL (3) IL148826A0 (pt)
MX (1) MXPA02003131A (pt)
WO (1) WO2001021184A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022527455A (ja) * 2019-03-19 2022-06-02 フィジーン、エルエルシー 活性化線維芽細胞及びそのエキソソーム誘導体を用いた慢性閉塞性肺疾患及び肺変性の治療

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
JPH04507041A (ja) * 1988-12-13 1992-12-10 アメリカ合衆国 遺伝工学により修飾された内皮細胞およびその利用方法
US5240846A (en) * 1989-08-22 1993-08-31 The Regents Of The University Of Michigan Gene therapy vector for cystic fibrosis
WO1992015676A1 (en) * 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Somatic cell gene therapy
WO1993013807A1 (en) * 1992-01-10 1993-07-22 Georgetown University A method of administering genetically engineered endothelial cells to sites of angiogenesis for effecting genetic therapy
CA2086844A1 (en) * 1993-01-07 1994-07-08 Ian D. Dube Method and product of gene transfer into cells
WO1998002170A1 (en) * 1996-07-17 1998-01-22 The General Hospital Corporation Method of inducing vasodilation and treating pulmonary hypertension using adenoviral-mediated transfer of the nitric oxide synthase gene
KR100695590B1 (ko) * 1996-11-01 2007-03-14 아크 테라퓨틱스 리미티드 산화질소 또는 프로스타시클린 생산을 자극하는 약제의 치료학적 용도 및 전달 기구
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
EP0893493A3 (de) * 1997-07-21 2002-12-04 Aventis Pharma Deutschland GmbH Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen
US6147109A (en) * 1997-10-14 2000-11-14 The General Hospital Corporation Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors
WO1999040197A2 (en) * 1998-02-06 1999-08-12 Collateral Therapeutics, Inc. Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
CA2227425A1 (en) * 1998-03-27 1999-09-27 An-Go-Gen Inc. Cell-based gene therapy
CA2266805C (en) * 1998-03-27 2015-04-28 An-Go-Gen Inc. Cell-based gene therapy in the treatment of pulmonary disorders

Also Published As

Publication number Publication date
IL192893A (en) 2014-03-31
EP1220679B1 (en) 2007-06-13
WO2001021184A1 (en) 2001-03-29
ATE364387T1 (de) 2007-07-15
IL148826A (en) 2010-12-30
JP2003509463A (ja) 2003-03-11
CA2383093A1 (en) 2001-03-29
ES2546937T3 (es) 2015-09-30
IL192893A0 (en) 2009-02-11
AU5724499A (en) 2001-04-24
IL148826A0 (en) 2002-09-12
EP1220679A1 (en) 2002-07-10
MXPA02003131A (es) 2003-08-20
EP1839667A3 (en) 2010-04-14
EP1839667B1 (en) 2015-06-17
DE69936320T2 (de) 2008-02-21
DE69936320D1 (de) 2007-07-26
EP1839667A2 (en) 2007-10-03

Similar Documents

Publication Publication Date Title
ATE307212T1 (de) Adenovirus-gelenkter gen-transfer zum herz-und glatten vaskulären muskel
FI955552A0 (fi) Adenoviraalisia eläinperäisiä vektoreita ja niiden käyttö geeniterapiassa
IL177228A0 (en) Use of a vector for the manufacture of a medicament for treating gaucher disease
ATE385810T1 (de) Verwendung von dna oder rna zur herstellung eines medikaments zur behandlung von tumoren
SE9702860L (sv) Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
DE69635899D1 (de) Polypeptid, das die differenzierung unterdrueckt
ATE420156T1 (de) Methode zur einführung von genetischem material in zellen
ES2077530A1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
EP0681475A4 (en) THERAPEUTIC INHIBITOR OF SMOOTH VASCULAR MUSCLE CELLS
GR3032457T3 (en) Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna.
WO1994006449A3 (en) Morphogen-induced liver regeneration
BR9917500A (pt) Terapia gênica baseada em célula para o sistema pulmonar
WO2003092598A3 (en) Treatment for pompe disease
WO2001005437A3 (en) Methods for treatment of hyperproliferative diseases using human mda-7
WO2000017375A3 (en) Method to treat haemophilia by in vivo gene therapy with retroviral vectors
GEP20012489B (en) Use of Natural Human α-Interferon
GB8727493D0 (en) Epidermal growth factor
PT1032429E (pt) Metodo para aplicacao de adn in vivo utilizando um aparelho sem agulha
James Gallo starts major AIDS research institute in Baltimore
CA2165271A1 (en) Reduction of adipose tissue
Sribuaphan TRADITIONAL MASSAGE IN THAILAND

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]

Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 16A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2324 DE 21-07-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.